
Sign up to save your podcasts
Or
In this episode of Beatwise The Podcast, I sit down with Dr. Andrew Flett, a consultant cardiologist in Southampton and the principal investigator of the British Trial, to explore a critical question in cardiology: Do all patients with heart failure due to non-ischemic cardiomyopathy need an implantable defibrillator (ICD)?
The British Trial, backed by a £1.8 million grant from the British Heart Foundation, aims to determine who truly benefits from ICDs - and who might not. We dive into the role of pacing in heart failure, the integration of medical therapies with pacemakers and defibrillators, and the potential risks and complexities involved. Dr. Flett shares the trial's origins, patient recruitment strategies, and how the findings could reshape future cardiac care.
If you’re a clinician, researcher, or patient interested in the latest advancements in heart failure treatment and defibrillator use, this episode is packed with insights you won’t want to miss!
If you enjoyed this episode, please like, rate, and subscribe to Beatwise The Podcast. Your support helps me reach more listeners and continue providing valuable content.
Don't forget to follow me on social media @sarah.theheartdoc for the latest updates, behind-the-scenes content, and more engaging discussions. Stay connected and be part of our growing community!
Hosted on Acast. See acast.com/privacy for more information.
In this episode of Beatwise The Podcast, I sit down with Dr. Andrew Flett, a consultant cardiologist in Southampton and the principal investigator of the British Trial, to explore a critical question in cardiology: Do all patients with heart failure due to non-ischemic cardiomyopathy need an implantable defibrillator (ICD)?
The British Trial, backed by a £1.8 million grant from the British Heart Foundation, aims to determine who truly benefits from ICDs - and who might not. We dive into the role of pacing in heart failure, the integration of medical therapies with pacemakers and defibrillators, and the potential risks and complexities involved. Dr. Flett shares the trial's origins, patient recruitment strategies, and how the findings could reshape future cardiac care.
If you’re a clinician, researcher, or patient interested in the latest advancements in heart failure treatment and defibrillator use, this episode is packed with insights you won’t want to miss!
If you enjoyed this episode, please like, rate, and subscribe to Beatwise The Podcast. Your support helps me reach more listeners and continue providing valuable content.
Don't forget to follow me on social media @sarah.theheartdoc for the latest updates, behind-the-scenes content, and more engaging discussions. Stay connected and be part of our growing community!
Hosted on Acast. See acast.com/privacy for more information.